Thryve Peptides
PT-141 (10mg)
PT-141 (10mg)
Couldn't load pickup availability
PT-141 10MG
Precision-tested peptide formulated for advanced research applications.
- PT-141 (Bremelanotide) is a synthetic peptide analog derived from the melanocortin family.
- Explored in laboratory settings for its potential role in melanocortin receptor activity and neuroendocrine signaling.
- Each batch independently verified by Vanguard Laboratory for identity and purity.
For laboratory research use only. Not for human consumption.
Scientific Evidence
PT-141 (Bremelanotide) is a cyclic heptapeptide analog of alpha-MSH that acts through melanocortin receptor pathways. It has been examined in laboratory and clinical research for its influence on neuronal signaling and vascular mechanisms (PubMed 17242534).
Studies have explored PT-141’s interaction with MC3R and MC4R receptors, providing insight into its broader peptide activity and receptor-specific mechanisms (PubMed 16424357).
Regulatory Status: PT-141 is not FDA-approved for human or veterinary use. This compound is supplied strictly for laboratory research applications.
